Return On Equity in % of Eiger BioPharmaceuticals, Inc. from Q3 2014 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Return On Equity history and change rate from Q3 2014 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Equity for the quarter ending 31 Dec 2023 was -870 %, a 650% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2023 was -870 %, a 650% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2022 was -116 %, a 240% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2021 was -34.2 %, a 62% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2023 -870 -754 -650% 01 Oct 2023 31 Dec 2023
Q3 2023 -332 -226 -212% 01 Jul 2023 30 Sep 2023
Q2 2023 -208 -110 -113% 01 Apr 2023 30 Jun 2023
Q1 2023 -143 -49.4 -53% 01 Jan 2023 31 Mar 2023
Q4 2022 -116 -81.8 -240% 01 Oct 2022 31 Dec 2022
Q3 2022 -106 -77 -261% 01 Jul 2022 30 Sep 2022
Q2 2022 -97.8 -74.7 -324% 01 Apr 2022 30 Jun 2022
Q1 2022 -93.2 -71.1 -322% 01 Jan 2022 31 Mar 2022
Q4 2021 -34.2 +55.7 +62% 01 Oct 2021 31 Dec 2021
Q3 2021 -29.5 +71.1 +70.7% 01 Jul 2021 30 Sep 2021
Q2 2021 -23.1 +92 +79.9% 01 Apr 2021 30 Jun 2021
Q1 2021 -22.1 +83.2 +79% 01 Jan 2021 31 Mar 2021
Q4 2020 -89.8 +15.4 +14.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -101 +0.19 +0.19% 01 Jul 2020 30 Sep 2020
Q2 2020 -115 -0.74 -0.65% 01 Apr 2020 30 Jun 2020
Q1 2020 -105 +15.9 +13.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -105 +22.3 +17.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -101 +54.8 +35.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -114 +42.4 +27% 01 Apr 2019 30 Jun 2019
Q1 2019 -121 +106 +46.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -127 +68.5 +35% 01 Oct 2018 31 Dec 2018
Q3 2018 -156 +13.6 +8.04% 01 Jul 2018 30 Sep 2018
Q2 2018 -157 -27.7 -21.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -227 -111 -96% 01 Jan 2018 31 Mar 2018
Q4 2017 -196 -97.2 -98.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -169 -103 -156% 01 Jul 2017 30 Sep 2017
Q2 2017 -129 -70.2 -119% 01 Apr 2017 30 Jun 2017
Q1 2017 -116 -46.3 -66.4% 01 Jan 2017 31 Mar 2017
Q4 2016 -98.9 -58.6 -145% 01 Oct 2016 31 Dec 2016
Q3 2016 -66.2 -58.2 -735% 01 Jul 2016 30 Sep 2016
Q2 2016 -58.8 -48.5 -474% 01 Apr 2016 30 Jun 2016
Q1 2016 -69.7 -79.9 -781% 01 Jan 2016 31 Mar 2016
Q4 2015 -40.3 -37.1 -1134% 01 Oct 2015 31 Dec 2015
Q3 2015 -7.92 +12.9 +62% 01 Jul 2015 30 Sep 2015
Q2 2015 -10.2 01 Apr 2015 30 Jun 2015
Q1 2015 10.2 01 Jan 2015 31 Mar 2015
Q4 2014 -3.27 01 Oct 2014 31 Dec 2014
Q3 2014 -20.8 01 Jul 2014 30 Sep 2014

Eiger BioPharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -870 -754 -650% 01 Jan 2023 31 Dec 2023
2022 -116 -81.8 -240% 01 Jan 2022 31 Dec 2022
2021 -34.2 +55.7 +62% 01 Jan 2021 31 Dec 2021
2020 -89.8 +15.4 +14.7% 01 Jan 2020 31 Dec 2020
2019 -105 +22.3 +17.5% 01 Jan 2019 31 Dec 2019
2018 -127 +68.5 +35% 01 Jan 2018 31 Dec 2018
2017 -196 -97.2 -98.3% 01 Jan 2017 31 Dec 2017
2016 -98.9 -58.6 -145% 01 Jan 2016 31 Dec 2016
2015 -40.3 -37.1 -1134% 01 Jan 2015 31 Dec 2015
2014 -3.27 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.